Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-43 is a small GTPase enzyme and a member of the Rab family, which functions as a key regulator of intracellular membrane trafficking[1][3][7]. Rab-43 cycles between inactive GDP-bound and active GTP-bound forms, recruiting effectors that mediate transport vesicle formation, movement, tethering, and fusion with target membranes[1][7]. The protein is involved in retrograde transport, particularly from endocytic compartments to the Golgi apparatus, and is required for the structural integrity of the Golgi complex[1][3][7]. It also plays a role in maturation of phagosomes, notably those that engulf pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis[1]. Although there are disease associations (e.g., certain cancers, Lynch syndrome 5, Smith-McCort dysplasia), there are currently no approved drugs listed as directly targeting this molecule[1][5][7].
No drugs with defined mechanisms of action specifically targeting RAB43 are reported in public literature or databases[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-43 (RAB43).